Disease volumes as a marker for patient response in malignant pleural mesothelioma

Author： Labby Z. E.   Nowak A. K.   Dignam J. J.   Straus C.   Kindler H. L.   Armato S. G.  

Publisher： Oxford University Press

ISSN： 0923-7534

Source： Annals of Oncology, Vol.24, Iss.4, 2013-04, pp. : 999-1005

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Wnt7A is a putative prognostic and chemosensitivity marker in human malignant pleural mesothelioma

By                                

Oncology Reports, Vol. 33, Iss. 4, 2015-01 ,pp. : 2052-2060

Spandidos Publications

Access to resources Recommend Favorite

Chemotherapy for Malignant Pleural Mesothelioma

By Garland Linda  

Current Treatment Options in Oncology, Vol. 12, Iss. 2, 2011-06 ,pp. : 181-188

Springer Publishing Company

Access to resources Recommend Favorite

Malignant pleural mesothelioma

By Stahel Rolf A   Felley-Bosco Emanuela   Opitz Isabelle   Weder Walter  

Future Oncology, Vol. 5, Iss. 3, 2009-04 ,pp. : 391-402

Future Medicine

Access to resources Recommend Favorite

Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma

By van Klaveren R.J.   Aerts J.G.J.V.   de Bruin H.   Giaccone G.   Manegold C.   van Meerbeeck J.P.  

Lung Cancer, Vol. 43, Iss. 1, 2004-01 ,pp. : 63-69

Elsevier

Access to resources Recommend Favorite

Surgical Treatment of Malignant Pleural Mesothelioma

By Kaufman Andrew  

Current Treatment Options in Oncology, Vol. 12, Iss. 2, 2011-06 ,pp. : 201-216

Springer Publishing Company

Access to resources Recommend Favorite